LEO Pharma Buying Peplin
LEO Pharma AS has agreed to acquire Peplin Inc. (ASX: PLI) for approximately US$287.5 million in cash. Peplin raised a $24 million PIPE last October from GBS Venture Partners, Asia Union Investments, MPM Capital, New Enterprise Associates and Orbis Funds Management.
4 September 2009•4 mins read
